The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...

A phase 3 study of eftilagimod alfa for NSCLC is ending early due to futility, according to an update from developer Immutep.

Phase shift analysis remains a cornerstone of modern scattering theory, underpinning our understanding of how particles interact under various potential fields. By examining the phase differences ...

Determining phase stability and evolution at elevated temperatures, as well as identifying the formation of new phases or the reaction temperature and pathway of a known solid-state reaction is a ...

Patients with advanced clear cell RCC whose disease progressed after 1-3 prior systemic therapies (including an anti–PD- [L]1 therapy) were randomly assigned 1:1 to belzutifan 200 mg or 120 mg daily: ...

The clinical database has been finalized for the pre-specified interim efficacy analysis in Diamyd Medical's ongoing pivotal Phase 3 trial (DIAGNODE-3) evaluating retogatein (rhGAD65) in individuals w ...

Phase 2 included development of the governance structure to ensure effective implementation. The roles and responsibilities of the Working Groups (WGs) and Deans Councils are finalized, and the ...